Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel

Due to its high mortality rate and asymptomatic nature, early detection rates of pancreatic ductal adenocarcinoma (PDAC) remain poor. We measured 1000 biomarker candidates in 134 clinical plasma samples by multiple reaction monitoring-mass spectrometry (MRM-MS). Differentially abundant proteins were...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jiyoung, Choi, Yonghwan, Namkung, Junghyun, Yi, Sung Gon, Kim, Hyunsoo, Yu, Jiyoung, Kim, Yongkang, Kwon, Min-Seok, Kwon, Wooil, Oh, Do-Youn, Kim, Sun-Whe, Jeong, Seung-Yong, Han, Wonshik, Lee, Kyu Eun, Heo, Jin Seok, Park, Joon Oh, Park, Joo Kyung, Kim, Song Cheol, Kang, Chang Moo, Lee, Woo Jin, Lee, Seungyeoun, Han, Sangjo, Park, Taesung, Jang, Jin-Young, Kim, Youngsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696248/
https://www.ncbi.nlm.nih.gov/pubmed/29190982
http://dx.doi.org/10.18632/oncotarget.21861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696248/
https://www.ncbi.nlm.nih.gov/pubmed/29190982
http://dx.doi.org/10.18632/oncotarget.21861

Ejemplares similares